v3.21.1
Condensed Consolidated Statements of Earnings (Unaudited) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Net revenues $ 13,010 $ 8,619
Cost of products sold 4,213 1,942
Selling, general and administrative 2,842 1,695
Research and development 1,782 1,379
Acquired in-process research and development 70 0
Total operating costs and expenses 8,907 5,016
Operating earnings 4,103 3,603
Interest expense, net 622 428
Net foreign exchange loss 9 5
Other expense (income), net (395) 72
Earnings before income tax expense 3,867 3,098
Income tax expense 312 88
Net earnings 3,555 3,010
Net earnings attributable to noncontrolling interest 2 0
Net earnings attributable to AbbVie Inc. $ 3,553 $ 3,010
Per share data    
Basic earnings per share (in dollars per share) $ 2.00 $ 2.02
Diluted earnings per share (in dollars per share) $ 1.99 $ 2.02
Weighted-average basic shares outstanding (in shares) 1,769 1,481
Weighted-average diluted shares outstanding (in shares) 1,775 1,484